Freestone Grove Partners LP Invests $36.72 Million in Revvity Inc. $RVTY

Posted by Brian Himes on Aug 27th, 2026

Freestone Grove Partners LP purchased a new stake in shares of Revvity Inc. (NYSE:RVTY – Free Report) during the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 330,003 shares of the company’s stock, valued at approximately $36,716,000.

Several other hedge funds also recently added to or reduced their stakes in RVTY. AQR Capital Management LLC increased its stake in Revvity by 5.2% during the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after acquiring an additional 420 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Revvity by 6.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC grew its holdings in shares of Revvity by 102.0% during the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after purchasing an additional 35,048 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Revvity by 45.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after purchasing an additional 189,871 shares during the last quarter. Finally, Focus Partners Wealth raised its holdings in Revvity by 13.0% in the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after buying an additional 811 shares during the period. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Stock Performance

NYSE:RVTY opened at $126.31 on Thursday. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $126.90. The company has a fifty day simple moving average of $112.94 and a two-hundred day simple moving average of $100.82. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The company has a market cap of $14.09 billion, a price-to-earnings ratio of 60.15, a price-to-earnings-growth ratio of 2.27 and a beta of 1.07.

Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The company’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period last year, the firm earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Evercore reaffirmed an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Barclays boosted their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Finally, Stifel Nicolaus lowered their price target on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research report on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $108.36.

Check Out Our Latest Stock Report on RVTY

Revvity Company Profile

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.